- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 155
Ascus Biosciences gets fed $46m
Cavallo Ventures contributed to a series B round for the microbial animal feed producer that will fund product development and recruitment.
May 29, 2020CFS fuses $84m with series A2
MIT's fusion energy spinout Commonwealth Fusion Systems secured the return of The Engine and Eni for a $84m series A2 round that followed a $115m series A last year.
May 28, 2020CFS sees out $84m series A2 round
Equinor and Eni Next contributed to an $84m round for nuclear fusion technology startup Commonwealth Fusion Systems following a $115m series A last year.
May 28, 2020Scandit puts $80m in the can
Salesforce Ventures, Swisscom Ventures and returning investor GV helped the computer vision technology provider take its total funding past $120m.
May 28, 2020Platform Science navigates $42m series B
The trucking management software provider secured $42m in a round led by Prologis Ventures that also featured new strategic partner Daimler.
May 27, 2020Oxford Nanopore expands latest round
Illumina and Amgen-backed genomic sequencing technology developer Oxford Nanopore has added $59.6m to a round that now totals $98.1m.
May 26, 2020Exscientia extracts $60m for series C round
OCD drug developer Exscientia bagged $60m in a Novo-led round that also featured Bristol-Myers Squibb and existing corporate investor Evotec.
May 26, 2020Exscientia extrapolates $60m series C
Novo has led a $60m series C round for University of Dundee’s Exscientia that also attracted Evotec, Bristol-Myers Squibb, and GT Healthcare Capital.
May 26, 2020MakeSpace stores $55m in series E
Iron Mountain has contributed to a $55m series E round that boosted the storage service provider's overall funding to more than $140m.
May 26, 2020GSK hits HotSpot in $65m series B
The cancer, autoimmune and rare disease drug developer completed a $65m round that also featured MRL Ventures Fund and Cleva Pharma.
May 26, 2020About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


